Skip to content
Open access

Design, synthesis, and biological evaluation of quinolin-2-one/thiazole hybrids as multi-targeted antiproliferative agents inducing caspase-dependent apoptosis

Sep 2026 · Scientific Reports · Vol 16 · 0 citations · 63 references
Medicine

TL;DR

Findings highlight compound 6b as a promising multi-kinase therapeutic scaffold for further targeted oncological optimization and highlighted that a 6-methyl substitution on the quinoline core, an unsubstituted N-1 position, and a bulky 3-phenyl group on the thiazole ring are key structural prerequisites for optimal anticancer activity.

Abstract

A novel series of quinolin-2-one/thiazole hybrids (6a–l) was designed, synthesized, characterized, and evaluated for their in vitro antiproliferative efficacy against three human cancer cell lines: HCT-116, MCF-7, and HepG-2. Most derivatives demonstrated good-to-moderate cytotoxic profiles. Among them, compound 6b emerged as the most potent lead candidate, with a mean IC50 of 4.20 µM, representing a 1.7-fold higher potency than the reference drug, sorafenib (IC50 = 6.80 µM). Specifically, compound 6b exhibited enhanced cytotoxicity against HCT-116 (IC50 = 5.20 µM) and MCF-7 (IC50 = 4.20 µM), and a two-fold higher potency against HepG-2 (IC50 = 3.20 µM) cells compared to sorafenib. Enzymatic assays revealed that 6b acts as an efficient multi-kinase inhibitor, effectively targeting EGFR (IC50 = 0.058 µM) and HER-2 (IC50 = 0.060 µM) with potencies comparable or superior to the standard controls erlotinib and lapatinib, while moderately inhibiting VEGFR-2 (IC50 = 0.51 µM). Safety screening against normal WI-38 cells showed low cytotoxicity (IC50 = 51.21 µM) and outstanding selectivity indices (SI > 10, > 12, and 16) for HCT-116, MCF-7, and HepG-2, respectively. Mechanistic investigations in HepG-2 cells confirmed that 6b induced a 6.9-fold increase in caspase-3/7 activity, triggering significant apoptosis. SAR analysis highlighted that a 6-methyl substitution on the quinoline core, an unsubstituted N-1 position, and a bulky 3-phenyl group on the thiazole ring are key structural prerequisites for optimal anticancer activity. These findings, along with docking investigation, highlight compound 6b as a promising multi-kinase therapeutic scaffold for further targeted oncological optimization.

Read PDF

Similar papers

Open access Sep 2026

Design, synthesis, and molecular modeling of quinoline-linked diphenylpyrazoles as multitarget EGFR, VEGFR-2, and COX-2 inhibitors with anticancer, anti-inflammatory and apoptosis-inducing properties.

A new series of quinoline-diphenylpyrazole hybrids were rationally designed, synthesized, and biologically evaluated as potential EGFR/VEGFR-2/COX-2 inhibitors, supporting the proposed hybrid design strategy.

Abdelrahman Hamdi, Mohamed R. Elnagar, M. Hussein et al. · 0 citations
Open access Sep 2026

Design, Synthesis, In Vitro Biological Evaluation, and In Silico Studies of Novel Imidazo[4,5-b]Pyridine-Acrylonitrile-Based Derivatives as VEGFR-2 Inhibitors Against Breast Cancer and Hepatocellular Carcinoma.

Vascular endothelial growth factor receptor-2 (VEGFR-2) is a vital mediator of angiogenesis. Therefore, VEGFR-2 inhibition is considered a promising therapeutic target to combat cancer. In the present study, a series of 22 imidazo[4,5-b]pyridine-acrylonitrile-based derivatives was designed and synthesized. All compound...

Lamia W. Mohamed, Ahmed A. Saadeldin, Ayman B. Farag · 0 citations
#protein folding Open access Oct 2026

New thiazole/coumarin hybrids as EGFR inhibitors with potential VEGFR-2 inhibition (design, synthesis, biological evaluation, and dynamic stimulation)

Two new series of coumarin–thiazole hybrids were designed and synthesized as EGFR/VEGFR-2 dual inhibitors and the most potent compounds (6a, 6h, and 9d) displayed remarkable inhibitory effectiveness against EGFR and VEGFR-2.

S. Elshemy, T. Ali, Ahmed M. Sayed et al. · 0 citations
Open access Nov 2026

Discovery of new indole-thiazolidin-4-one hybrid derivatives as anticancer agents: Synthesis, biological evaluation, molecular docking toward VEGFR-2 , and DFT studies.

A new series of indole–thiazolidin-4-one hybrid derivatives ( IN-1–IN-5 ) was designed and synthesized as potential anticancer agents by integrating two biologically privileged scaffolds into a single molecular framework. The compounds were characterized using standard spectroscopic techniques and evaluated for the...

Z. H. Alnakhli, Shorog Alotaiby, H. Alshareef et al. · 0 citations
Oct 2026

Benzodiazepine-based N,S-heterocyclic hybrids as multi-target therapeutic candidates for cancer and inflammation: enzymatic evaluation, cellular mechanistic studies, in vivo anti-inflammatory assessment, and computational investigations.

A series of eleven novel benzodiazepine-based N, S-heterocyclic hybrids incorporating thienothiazine and thienopyrimidine scaffolds was designed, synthesized, and characterized by spectroscopic and analytical techniques. Compounds 4 and 6 showed favorable selectivity against HCT-116 and MDA-MB-231 cells relative to nor...

Hagar S. El-Hema, M. A. Abed, M. A. Hawata et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.